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Persons with early-stage Parkinson’s disease (EPD) do not typically experience marked functional deﬁcits but may have diﬃculty
with turning tasks. Studies evaluating turning have focused on individuals in advanced stages of the disease. The purpose of this
study was to compare postural control strategies adopted during turning in persons with EPD to those used by healthy control
(HC) subjects. Fifteen persons with EPD, diagnosed within 3 years, and 10 HC participated. Participants walked 4 meters and then
turned 90◦. Dynamic postural control was quantiﬁed as the distance between the center of pressure (COP) and the extrapolated
center of mass (eCOM). Individuals with EPD demonstrated signiﬁcantly shorter COP-eCOM distances compared to HC. These
ﬁndings suggest that dynamic postural control during turning is altered even in the early stages of PD.
1.Introduction
Postural control is the ability to alter the magnitude and
patterns of segmental kinematics (e.g., trunk and limb
movements) in order to direct body position in response
to external mechanical demands imposed during static and
dynamic tasks such as turning [1, 2]. Functional indepen-
dence, and consequently quality of life, is compromised in
individuals with postural control deﬁcits. Persons with early-
stage Parkinson’s disease (EPD), Hoehn and Yahr stage 1
and 2, may not demonstrate overt clinical symptoms and
may describe only minimal levels of functional impairment,
such as reduced gait velocity and stride length, during
simple movement tasks including straight walking [3, 4].
However, they often demonstrate altered postural control
during standing tasks [5] and report diﬃculty with turning
[6]. Turning diﬃculty becomes a sensitive indicator of a
higher prevalence of freezing and falling in persons with
advanced PD (Hoehn and Yahr stage ≥3w i t hm o d e r a t et o
severe symptoms) [7, 8].
Turning is a challenging task that aims to transport the
body’s mass in a new direction. It requires deceleration ofthe
body’s center of mass (COM; the position that represents the
equilibrium point of the body’s mass), rotation of the axial
segments, and acceleration of the COM in the new direction
[9, 10]. This is accomplished in three consecutive steps:
approach, pivot, and acceleration steps embedded within
two phases. During these phases individuals transition from
double limb to single limb stance before returning to double
limb stance [11]. Studies have established that in young,
healthy individuals the redirection of the COM into the
new direction of travel is initiated through appropriate foot
placementduringphase1(fromapproachsteptopivotstep).
During phase 2 (from pivot step to acceleration step) trunk
movements are used to control turning [12].
The demands of turning present unique challenges to
individuals with impaired postural control as they are
required to initiate a state of disequilibrium during single
limb stance in order to change directions during an ongoing
movement [9, 13]. This disequilibrium is created by increas-
ing the distance between the body’s COM and the center of
pressure (COP; the equilibrium point of the distribution of
the resultant ground reaction force applied to the base of
support). An increased distance between these two points
not only creates momentum necessary to turn, but also
requires increased neuromuscular control (e.g., neural drive,2 Parkinson’s Disease
Table 1: Mean and standard deviation of participant’s characteristics.
Group
EPD (n = 15) HC (n = 10) Diﬀerences (95% CI)
Age (yr) 62 (9.1) 60 (8.5) 2 (−5.49; 9.49)
Height (m) 1.68 (0.07) 1.72 (0.09) −0.04 (−0.11; 0.03)
Weight (kg) 68.9 (12.1) 74.8 (17.2) −5.9 (−17.99; 6.19)
Approach gait velocity (m/s) 1.35 (0.14) 1.46 (0.14) −0.11 (−0.23; 0.01)
Mean (Standard Deviation).
EPD: persons with early-stage Parkinson’s disease.
HC: healthy control participants.
muscle forces, and joint power) to redirect and control this
momentum. Alterations in turning strategies are thought
to reﬂect an individual’s inability to meet these increased
neuromuscular demands. For example, when compared
to healthy controls, persons diagnosed with advanced PD
utilize postural control strategies that include longer turning
times [14] along with a greater number of smaller steps
[8, 14] to complete a turn. These postural adjustments
serve to decrease the body’s momentum, reduce the distance
between the COM and the COP, and in turn decrease
the neuromuscular demands. While alterations in postural
control strategies have been observed in individuals with
advancedPD,theyhavenotbeencharacterizedinindividuals
diagnosed with EPD.
Individuals diagnosed with EPD do report diﬃculty
turning [6]. However, in contrast to individuals diagnosed
with advanced PD, they do not frequently exhibit observable
movement impairments that could impact turning such as
shuﬄing gait, freezing episodes, and en bloc movements.
[3, 4, 15, 16]. A more detailed evaluation of postural
control strategies employed by individuals diagnosed with
EPD during turning is needed. However, more traditional
measures of postural control that relate the distance between
the positions of the COP and COM may not be sensitive
enough to detect diﬀerences between individuals diagnosed
with EPD and healthy controls because they do not take
into account the dynamic nature of the turning task. During
dynamic tasks it is important to consider not only the
position of the COM but also the magnitude and direction
of the COM velocity in relation to the COP [17, 18].
Despite self-reports of diﬃculty turning in persons with
EPD, studies to date have not characterized the postural
control strategies used during turning in this cohort. Early
identiﬁcation of these strategies may be used to develop
eﬀective intervention protocols that (1) improve turning
capabilities and (2) increase balance conﬁdence in persons
with EPD. Therefore, the purpose of this study was to
characterize the diﬀerences in postural control during a step
turning activity, between persons with EPD and healthy
age-matched control (HC) participants. We hypothesized
that, compared to HC participants, persons with EPD
would demonstrate a dynamic postural control strategy
that reduced the demands on the neuromuscular system.
Speciﬁcally, we hypothesized that when accounting for the
position, magnitude and velocity of the COM persons with
EPD would demonstrate shorter distances between the COP
and the eCOM than healthy controls during both phases of a
step turn at 90 degrees. Moreover, this will be accomplished
by both decreasing their COM velocity and the distance
between their COP and the COM.
2. Methods
2.1. Participants. Fifteen persons with EPD and 10 HC sub-
jects participated. Participant characteristics are provided in
Table 1. A fellowship-trained movement disorder specialist
conﬁrmed diagnosis of idiopathic PD in our participants,
performed the Uniﬁed Parkinson’s Disease Rating Scale
(UPDRS), and determined Hoehn and Yahr stage for each
individual participant. Participants that had pharmacologi-
cal treatment were stable and tested while they were on their
routine therapy (Table 2). At the time of testing, none of
the participants exhibited any ﬂuctuations in motor ability
throughout the day, dyskinesia, dystonia, or other signs of
involuntary movement.
The inclusion criteria for the early PD group were the
following: (1) age ≥18 years old, (2) able to ambulate at
least 14 meters (time not measured) without a walker or
other devices, (3) diagnosed with PD within 3 years [19],
(4) Hoehn and Yahr stages 1-2 (indicating EPD), and (5)
stable on PD medications. Healthy control participants were
age and gender-matched to the participants in the early PD
cohort. Participants were excluded from the study for the
following: (1) surgical intervention for persons with PD, (2)
Mini-MentalStateExam(MMSE)score<24[20],(3)comor-
bidities aﬀecting gait (e.g., diabetes, musculoskeletal injury,
arthritis, vestibular disorders), (4) severe vision problems,
and (5) pregnancy.
2.2. Protocol. All testing took place in the Musculoskeletal
Biomechanics Research Laboratory at the University of
Southern California (USC). Procedures were explained to
each participant and each participant signed an informed
consent form approved by the Institutional Review Board of
the USC. Participants were instructed to walk straight at a
“self-selected, comfortable pace and turn at the designated
stanchions at a right angle” toward their dominant leg and
then continue walking in the new direction (Figure 1).
Prior to testing the dominant leg was determined as the leg
they would use to kick a ball as far as possible. No other
instructions were given to the participants. The subjectsParkinson’s Disease 3
Table 2: Dosage of Parkinson’s medications.
Participant number Medication Dosage Frequency
P01 Levodopa/carbidopa 25–100mg 3x/day
P02 De Novo
P03
Pramipexole 1mg 3x/day
Rasagiline 1mg 1x/day
Levodopa/carbidopa 50–200mg 3x/day
P04 De Novo
P05 Pramipexole 1.5mg 3x/day
Selegiline 5mg 2x/day
P06 Rasagiline 1mg 1x/day
Amantadine 100mg 2x/day
P07 De Novo
P08 Rasagiline 1mg 1x/day
Trihexyphenidyl 4 to 6mg 1x/day
P09 Levodopa/carbidopa 150mg 3x/day
P10 Pramipexole 0.75mg 3x/day
Rasagiline 1mg 1x/day
P11 Pramipexole 1.5mg 3x/day
Rasagiline 1mg 1x/day
P12 Levodopa/carbidopa 25–100mg 4x/day
P13 Levodopa/carbidopa 25–100mg 3x/day
Rasagiline 0.5mg 1x/day
P14 Pramipexole 0.5mg 3x/day
P15
Pramipexole 1.5mg 3x/day
Selegiline 5mg 2x/day
Trihexyphenidyl 2mg 3x/day
A
B
Starting point
2.4m
1m
4m
0.6m
Figure 1: Laboratory setup. Dashed line: starting point; A: ﬁrst trigger; B: second trigger; black square: force plate (AMTI 1.2m × 1.2m,
1560Hz). Two stanchions were placed at the midpoint of each force plate. Starting point to A: 1m. A to B: 2.4m. B to force plate: 0.6m.
Force plate to stanchions: 0.6m.4 Parkinson’s Disease
started 1 meter from the ﬁrst timing trigger. They then
walked for an additional 2.4 meters before walking through
the second timing trigger, which was located 0.6 meters in
front of the force plate.
A total of 10 turning trials were recorded for each
participant.Theﬁrstthreesuccessfultrialsduringwhichthey
used a step turn strategy were considered for analysis. A step
turn is deﬁned as a change in direction opposite to the pivot
foot [10, 13]. Ninety-degree turns were selected for analysis
because these types of turns are associated with the naviga-
tion of corridors, street corners, and other common walking
activities. Moreover, Sedgman and colleagues reported that
the majority of turns experienced during activities of daily
living were between 76◦ and 120◦ [21].
Kinematic data were sampled at 60Hz using a motion
analysis system (Vicon 612, Oxford Metrics Ltd., Oxford,
England). Reﬂective markers (14mm spheres) were placed
bilaterally on the skin over speciﬁc anatomical landmarks
including the anterior, posterior, and lateral cranium, acro-
mion processes, anterior and posterior shoulders, greater
tubercles of humerus, medial and lateral humeral epi-
condyles, radial styloid process, ulnar head, third metacar-
pophalangeal joints, 7th cervical vertebrae, sternoclavicular
notch, iliac crests, anterior superior iliac spines, poste-
rior superior iliac spines, L5-S1 joint, medial and lateral
femoral epicondyles, medial and lateral malleoli, ﬁrst and
ﬁfth metatarsal heads, and ﬁrst proximal/distal phalanx.
Additionally, cluster markers were placed with a band over
the upper arms, lower arms, thighs, shanks, and shoe
heels. Reﬂective markers were identiﬁed manually within
the VICON Workstation software and then imported into
Visual 3D software (C-Motion, Rockville, MD). 3D marker
coordinates were lowpass ﬁltered at a cut-oﬀ frequency of
6Hz.
Kinetic data were captured using 1.2m × 1.2m AMTI
(Advanced Mechanical Technologies, Inc., Newton, MA,
USA) force platform at 1560Hz. The size of the plat-
form allowed for quantiﬁcation of ground reaction forces
throughout the entire task. Kinematic and kinetic data
were interfaced to the same microcomputer allowing for
synchronization of data.
2.3.DataAnalysis. Dynamicposturalcontrolduringturning
was quantiﬁed using the method previously described by
Hof (1)[ 17]. It was deﬁned as the diﬀerence between the
COP and an extrapolated COM calculated to account for the
position, magnitude and velocity of the COM:
Dynamic Postural Control = COP −

COG +
COMvel
√
g/l


.
(1)
The COP was determined from the forces and moments
obtained from the force platform. The position of the
total body COM was deﬁned using the weighted sum of
the COM of all 15-body segments. Based on Winter [22],
instantaneous velocity of the total body COM (COMvel)
Approach
step
Pivot
step
Acceleration
step
Phase 2
P
h
a
s
e
1
Stanchions Stanchions
Figure 2: Schematic representation of the COP and the eCOM
trajectories during the step turn. Solid line: eCOM trajectory;
dashed gray line: COP trajectory; Phase 1: from approach step to
pivot step; Phase 2: from pivot step to acceleration step.
was computed from the linear total body COM positions
(COMpos):
COMveln =

COMposn+1− COMposn −1

Δt
,( 2 )
where, n is the event frame, and Δt is the time between event
frames.
The center of gravity (COG) represents the vertical
projection of the body’s COM. It was calculated based on
the medial-lateral and the anterior-posterior locations of
the COM. The COM velocity was divided by the natural
frequency of the limb. The natural frequency was calculated
as
√
(g/l)w h e r eg is the acceleration of gravity and l is the
length of the leg measured from the ankle joint center to
the COM. The extrapolated COM (eCOM) was calculated
as sum of the COG and the new COM velocity term:
eCOM =

COG +
COMvel
√
g/l


. (3)
The turning cycle was deﬁned from heel strike of the
approach step to heel strike of the acceleration step and was
broken into 2 phases. Phase 1 was deﬁned from heel strike of
the approach step to heel strike of the pivot step. Phase 2 was
deﬁned from heel strike of the pivot step to heel strike of the
accelerationstep(Figure2).Thedependentvariabledynamic
postural control was measured as the peak distance between
the COP and the eCOM. Peak distance between the COP
and the COG, and the peak COM velocity were identiﬁed
for each phase. These measures were considered in the case
in which dynamic postural control diﬀered between groups,
as alterations in both position and velocity can aﬀect this
measure of dynamic postural control. The average approach
gait velocity across three successful trials was calculated
over the 2.4 meters between the ﬁrst trigger (A) and the
second trigger (B) during turning (Figure 1). The single- and
double-limb gait cycle phases were determined using force
plate contact and the vertical velocity of the virtual center of
each foot [23].
2.4. Statistical Analysis. To determine if diﬀerences in
our dependent variable, dynamic postural control, existedParkinson’s Disease 5
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Figure 3: Resultant COP-eCOM distance (a), and resultant COP-COG distance (b), resultant COM velocity (c) between groups during the
step turn cycle (±sd). HS: heel strike; TO: toe oﬀ; light gray line: persons with early-stage Parkinson’s disease; black line: healthy control
participants; gray shadow: double limb support time; white shadow: single limb support time. †denotes statistically signiﬁcant diﬀerence
between groups (P<0.05). ∗denotes statistically signiﬁcant diﬀerence between phases (P<0.05).
between persons with EPD and HC participants across
turning phases, a 2 × 2( g r o u p× phase) ANOVA was
performed. In the case in which diﬀerences in dynamic
postural control were found between groups, independent
t-tests were performed to determine if group diﬀerences
existed in the input variables used to calculate dynamic
postural control, position of the COG relative to the COP,
and the COM velocity within each phase. All statistical
analyses were performed using SPSS 15.0 (Chicago, IL) with
an alpha level set at 0.05.
3. Results
Participant characteristics and approach gait velocity are
provided in Table 1. There were no signiﬁcant group
diﬀerences for age, height, weight, or approach gait velocity
(P>0.05). In the EPD group, average time since diagnosis
was 18.2 ± 13.9 months, average H&Y score was 1.9 ± 0.3,
and average UPDRS motor score was 21.2 ± 6.7. Average
UPDRS gait and postural stability subscores were 0.1 ± 0.4
and 0.3 ±0.5, respectively.
No signiﬁcant group by phase interaction was found for
dynamic postural control (F = 0.584, P = 0.453). Main
eﬀe c t so fg r o u pa n dp h a s ea r ef o u n df o rd y n a m i cp o s t u r a l
control. Persons with EPD demonstrated statistically signif-
icant smaller peak COP-eCOM distances compared to HC
participants during both Phase 1 (20.6% diﬀerence; 0.34 ±
0.05 versus 0.41 ± 0.06m; P<0.01) and Phase 2 (21.1%
diﬀerence; 0.38 ± 0.06 versus 0.46 ± 0.07m; P = 0.01) of the
step turn (Figure 3(a)). The peak distance between the COP
and the eCOM always occurred during single limb stance
within each of the phases.
Compared to control participants, persons with EPD
demonstrated statistically signiﬁcant smaller peak COP-
COGdistancesduringbothPhase1(30.8%diﬀerence;0.13±
0.03 versus 0.17 ± 0.03m; P<0.01) and Phase 2 (28.6%
diﬀerence; 0.21 ± 0.05 versus 0.27 ± 0.04m; P<0.05;
Figure 3(b)).6 Parkinson’s Disease
Although there was no signiﬁcant diﬀerence in the
average approach gait velocity between groups, persons with
EPD exhibited signiﬁcantly slower peak COM velocity when
compared with control participants during phase 1 (14%
diﬀerence; 0.64 ± 0.10 versus 0.74 ± 0.10m/s) and phase 2
(35% diﬀerence; 0.41±0.11 versus 0.63±0.08m/s; P<0.05;
Figure 3(c)) of the turning cycle.
4. Discussion
This study identiﬁed diﬀerences in dynamic postural control
strategies in persons with EPD during step turning activities
comparedtoHCparticipants.UsingtheeCOM,wewereable
to account for not only the position of the COM but also
the magnitude and velocity. This is particularly important
during turning as the momentum of the COM is needed for
forward propulsion and redirection. We found that persons
with EPD utilized shorter distances between the COP and
the eCOM during both phases of the turning cycle. For
both phases the group diﬀerences were noted during single
limb stance. This suggests that during a time in which
postural control demands are greatest, individuals with EPD
adopt a strategy that aims to decrease these demands. It
is also important to note that the diﬀerences observed in
postural control between the groups appear to be largely
driven by alterations in magnitude, not timing, suggesting
that individuals with EPD are not adopting an entirely new
strategy but merely scaling the strategy typically used to turn
(Figure 3).
Persons with EPD appeared to scale both position and
velocity of the COM: factors used to calculate postural
control in this study. Both the shorter peak distance between
the COP and the COG, and the slower peak COM velocity
exhibited by individuals with EPD during the turn limit the
disequilibrium experienced by the individual. Both of these
adjustments have the potential to decrease neuromuscular
demands.AsmallerCOP-COGdistancereducesthemoment
arm created for the body weight vector acting around
the centers of joint rotation, and thus the magnitude of
the muscular force required to control the COM [24].
Additionally, a slower COM velocity reduces the momentum
of the COM and decreases the muscular force required to
decelerate and redirect the COM.
These alterations are consistent with what has been
observed in persons with more advanced PD (longer turning
time and smaller steps) during turning [8, 14, 25]. The
current data support self-reports of “diﬃculty in turning”
from persons with EPD [6]. Our ﬁndings are similar to
those reported by researchers investigating other transitional
movement patterns in persons with more advanced PD,
namely gait initiation and sit-to-walk activities. For example,
Martin and colleagues [26] reported a shortening of the
separation between the COM and the COP during gait
initiation in persons with PD, compared to healthy older
adults. Moreover, Buckley and colleagues [27]r e p o r t e d
that compared to healthy control subjects, persons with
PD utilized a conservative movement strategy that limited
separation of COP-COM during sit-to-walk transitions. We
demonstratedthatwhenwechallengedindividualswithEPD
with a turning task, alterations in postural control similar to
those seen in more advanced stages were observed. This is of
particular importance since this group does not commonly
demonstrate obvious signs of gait disturbance [3, 4].
Although the current ﬁndings describe adjustments in
postural control in individuals with EPD, they are not
suﬃcient to tease out whether or not the COP-eCOM
diﬀerence is a primary deviation or a secondary compensation
of the disease. The reduced COM velocity demonstrated by
our participants is in agreement with previous reports of
slower turning velocity in persons with PD (i.e., task-speciﬁc
bradykinesia) [14, 25]. As discussed, our data demonstrate
that persons with EPD utilize a scaled motor control strategy
that limits separation of the COP and the eCOM. This
could be due to lack of neuromuscular control of the COM,
limb and trunk position, or the result of bradykinesia or
rigidity-primary deviations associated with compromised
basal ganglia function. Alternatively, the ﬁndings may also
be the result of secondary compensation of the disease. For
example, this strategy could be adopted due to the inability
to generate appropriate momentum or the presence of
neuromuscular deﬁcits, which limit adequate muscular force
production [26, 28]. While we did not directly measure
muscular force, our ﬁndings are consistent with reports of
reduced lower extremity force generation in persons with
PD [29]. In aggregate, the cross-sectional designs of the
previously mentioned studies and the absence of strength
measures in the current study limit our ability to tease
out whether or not the shorter COP-eCOM diﬀerences are
primarydeviationsrelatedtoalackofneuromuscularcontrol
or secondary compensation of the disease. Future studies that
incorporate longitudinal designs and strength measures will
ultimately be required to delineate these underlying factors.
A limitation of the study is that we only examined
one walking speed, one turning direction, and one turn-
ing angle. Speciﬁcally, the participants were instructed to
walk at their self-selected, comfortable pace and then turn
to their dominant side at the stanchions and continue
walking in the new direction. Although the instructions
for participants to walk at their “self-selected, comfort-
able pace” were instituted in order to assess participants
during their most frequently utilized walking speeds, these
instructions are likely to have increased the variability of
walking speed across subjects. It is not clear, however, if
increased walking-speed variability would also increase the
variability of our primary outcome variable, COP-eCOM,
because participants may select a safe turning strategy that
preserves COP-eCOM distance, independent of walking
speed. Moreover, individuals will often have to modify their
movement speed (either slowing or speeding-up) during
ADLsinresponsetoexternal/environmentalconditions(e.g.,
weather, traﬃc lights, ground/ﬂoor frictional characteristics,
obstacles, etc.). Thus, future studies should examine the
eﬀectsof speed on postural control during turning in persons
with PD, and include trials “as fast as possible”, “as safe as
possible”, and at other predetermined speeds. Additionally,
in order to navigate successfully, people must turn both
right and left and negotiate a variety of turning angles
(although the majority of turns experienced during ADLsParkinson’s Disease 7
are between 76◦ and 120◦)[ 21]. These additional directions
and turning angles should also be examined in future study
designs.
This study also did not examine the inﬂuence of med-
ication on turning behavior and COP-eCOM. Participants
that had pharmacological treatment were stable with no
ﬂuctuations of PD symptoms and tested while they were on
their routine therapy. At the time of testing, none of the
participants exhibited dyskinesia, dystonia, or other signs of
involuntary movement. Thus, whether or not COP-eCOM
distances would have been diﬀerent had the participants not
been on their routine therapy cannot be inferred from the
current investigation. In a recent report, Hong and Earhart
reported that although medication signiﬁcantly improved
UPDRS scores and walking velocity, it did not statistically
signiﬁcantly alter turning performance [30]. The authors
went on, however, to report that “there was evidence for
[turning] improvements particularly with respect to the
amplitudes of relative rotation between segment rotations
with eﬀect sizes ranging from 0.42 to 0.70.” They noted
that their “...results suggest that only certain features of
impaired turning may be responsive to anti-Parkinson’s
medication.” The participants in the Hong and Earhart study
were older and had more advanced PD than participants in
the current study—making extrapolation of their ﬁndings to
the current investigation diﬃcult. We hypothesize, however,
that medication eﬀects on turning in persons with early
PD will be less evident. Additional studies investigating the
inﬂuence of medication on COP-eCOM during turning will
be needed in persons with EPD to test this hypothesis.
Despite these limitations, the results of the current
study provide important additional evidence that functional
impairments can be detected even in the early stages of the
disease, when clinical signs of gait disturbance are often
absent [5, 31]. Taken together, these reports suggest that
identifying the movement limitations associated with EPD
requires examination of more complex tasks that increase
the challenge to the neuromuscular system, such as turning
and gait initiation. The ﬁndings also suggest that the peak
COP-eCOM distance generated during turning activities
may be a useful index for quantifying disease severity and
intervention eﬀectiveness. In order to determine whether the
posturalcontrolstrategiesduringstepturningaresensitiveto
disease severity, additional studies that examine individuals
across a broader range of disease severity will be necessary.
Additionally,studieswillbeneededtodelineatetheinﬂuence
of rehabilitation interventions on postural control during
turning in persons with EPD.
5. Conclusion
Compared to HC participants, persons with EPD altered
their postural control strategies (shorter distance between
the COP and the eCOM) during the step turn. Persons with
EPD appear to decrease their overall movement amplitude
(i.e., COM displacement, velocity) suggesting that dynamic
postural control during turning is altered even in the early
stages of PD.
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